128 related articles for article (PubMed ID: 38446668)
1. Mosaic deletion of claudin-5 reveals rapid non-cell-autonomous consequences of blood-brain barrier leakage.
Vázquez-Liébanas E; Mocci G; Li W; Laviña B; Reddy A; O'Connor C; Hudson N; Elbeck Z; Nikoloudis I; Gaengel K; Vanlandewijck M; Campbell M; Betsholtz C; Mäe MA
Cell Rep; 2024 Mar; 43(3):113911. PubMed ID: 38446668
[TBL] [Abstract][Full Text] [Related]
2. Specific binding of a mutated fragment of Clostridium perfringens enterotoxin to endothelial claudin-5 and its modulation of cerebral vascular permeability.
Liao Z; Yang Z; Piontek A; Eichner M; Krause G; Li L; Piontek J; Zhang J
Neuroscience; 2016 Jul; 327():53-63. PubMed ID: 27095710
[TBL] [Abstract][Full Text] [Related]
3. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.
Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J
Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550
[TBL] [Abstract][Full Text] [Related]
4. AKT2 maintains brain endothelial claudin-5 expression and selective activation of IR/AKT2/FOXO1-signaling reverses barrier dysfunction.
Beard RS; Hoettels BA; Meegan JE; Wertz TS; Cha BJ; Yang X; Oxford JT; Wu MH; Yuan SY
J Cereb Blood Flow Metab; 2020 Feb; 40(2):374-391. PubMed ID: 30574832
[TBL] [Abstract][Full Text] [Related]
5. Autophagy alleviates hypoxia-induced blood-brain barrier injury via regulation of CLDN5 (claudin 5).
Yang Z; Lin P; Chen B; Zhang X; Xiao W; Wu S; Huang C; Feng D; Zhang W; Zhang J
Autophagy; 2021 Oct; 17(10):3048-3067. PubMed ID: 33280500
[TBL] [Abstract][Full Text] [Related]
6. The CLDN5 gene at the blood-brain barrier in health and disease.
Hashimoto Y; Greene C; Munnich A; Campbell M
Fluids Barriers CNS; 2023 Mar; 20(1):22. PubMed ID: 36978081
[TBL] [Abstract][Full Text] [Related]
7. Claudin-5 regulates blood-brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis.
Ma SC; Li Q; Peng JY; Zhouwen JL; Diao JF; Niu JX; Wang X; Guan XD; Jia W; Jiang WG
CNS Neurosci Ther; 2017 Dec; 23(12):947-960. PubMed ID: 28961379
[TBL] [Abstract][Full Text] [Related]
8. Claudin-5a knockdown attenuates blood-neural barrier in zebrafish.
Ahn JC; Hwang SJ; Lee HJ; Kim KW
Comp Biochem Physiol C Toxicol Pharmacol; 2021 Dec; 250():109176. PubMed ID: 34500089
[TBL] [Abstract][Full Text] [Related]
9. Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells.
Roudnicky F; Zhang JD; Kim BK; Pandya NJ; Lan Y; Sach-Peltason L; Ragelle H; Strassburger P; Gruener S; Lazendic M; Uhles S; Revelant F; Eidam O; Sturm G; Kueppers V; Christensen K; Goldstein LD; Tzouros M; Banfai B; Modrusan Z; Graf M; Patsch C; Burcin M; Meyer CA; Westenskow PD; Cowan CA
Proc Natl Acad Sci U S A; 2020 Aug; 117(33):19854-19865. PubMed ID: 32759214
[TBL] [Abstract][Full Text] [Related]
10. The region-selective regulation of endothelial claudin-5 expression and signaling in brain health and disorders.
Chiba H; Ichikawa-Tomikawa N; Imura T; Sugimoto K
J Cell Physiol; 2021 Oct; 236(10):7134-7143. PubMed ID: 33694168
[TBL] [Abstract][Full Text] [Related]
11. Disheveled-1 Interacts with Claudin-5 and Contributes to Norrin-Induced Endothelial Barrier Restoration.
Díaz-Coránguez M; González-González L; Wang A; Liu X; Antonetti DA
Cells; 2023 Oct; 12(19):. PubMed ID: 37830616
[TBL] [Abstract][Full Text] [Related]
12. Non-muscle Mlck is required for β-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1β-mediated barrier dysfunction in brain endothelial cells.
Beard RS; Haines RJ; Wu KY; Reynolds JJ; Davis SM; Elliott JE; Malinin NL; Chatterjee V; Cha BJ; Wu MH; Yuan SY
J Cell Sci; 2014 Apr; 127(Pt 8):1840-53. PubMed ID: 24522189
[TBL] [Abstract][Full Text] [Related]
13. Computational Assessment of Different Structural Models for Claudin-5 Complexes in Blood-Brain Barrier Tight Junctions.
Berselli A; Alberini G; Benfenati F; Maragliano L
ACS Chem Neurosci; 2022 Jul; 13(14):2140-2153. PubMed ID: 35816296
[TBL] [Abstract][Full Text] [Related]
14. CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating blood‑brain barrier permeability in tumor brain metastasis.
Ma SC; Li Q; Peng JY; Zhouwen JL; Zhang DN; Zhang CB; Jiang WG; Jia W
Oncol Rep; 2018 Mar; 39(3):1441-1453. PubMed ID: 29328410
[TBL] [Abstract][Full Text] [Related]
15. Tight junction proteins at the blood-brain barrier: far more than claudin-5.
Berndt P; Winkler L; Cording J; Breitkreuz-Korff O; Rex A; Dithmer S; Rausch V; Blasig R; Richter M; Sporbert A; Wolburg H; Blasig IE; Haseloff RF
Cell Mol Life Sci; 2019 May; 76(10):1987-2002. PubMed ID: 30734065
[TBL] [Abstract][Full Text] [Related]
16. A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood-brain barrier models for drug transport studies.
Gericke B; Römermann K; Noack A; Noack S; Kronenberg J; Blasig IE; Löscher W
Fluids Barriers CNS; 2020 Aug; 17(1):53. PubMed ID: 32843059
[TBL] [Abstract][Full Text] [Related]
17. Lowering of brain endothelial cell barrier function by exposure to 4'-iodo-α-pyrrolidinononanophenone.
Sakai Y; Taguchi M; Morikawa Y; Suenami K; Yanase E; Takayama T; Ikari A; Matsunaga T
Chem Biol Interact; 2022 Sep; 364():110052. PubMed ID: 35872046
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier dysfunction mediated by the EZH2-Claudin-5 axis drives stress-induced TNF-α infiltration and depression-like behaviors.
Sun ZW; Wang X; Zhao Y; Sun ZX; Wu YH; Hu H; Zhang L; Wang SD; Li F; Wei AJ; Feng H; Xie F; Qian LJ
Brain Behav Immun; 2024 Jan; 115():143-156. PubMed ID: 37848095
[TBL] [Abstract][Full Text] [Related]
19. Modeling of Blood-Brain Barrier (BBB) Dysfunction and Immune Cell Migration Using Human BBB-on-a-Chip for Drug Discovery Research.
Ohbuchi M; Shibuta M; Tetsuka K; Sasaki-Iwaoka H; Oishi M; Shimizu F; Nagasaka Y
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928202
[TBL] [Abstract][Full Text] [Related]
20. Recurrent de novo mutations in CLDN5 induce an anion-selective blood-brain barrier and alternating hemiplegia.
Hashimoto Y; Poirier K; Boddaert N; Hubert L; Aubart M; Kaminska A; Alison M; Desguerre I; Munnich A; Campbell M
Brain; 2022 Oct; 145(10):3374-3382. PubMed ID: 35714222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
